Preparation of poly (epsilon-caprolactone) microspheres containing etoposide by solvent evaporation method

Asian Journal of Pharmaceutical Sciences

Volumn 5, Issue 3, 2010, Pages 114-122

  Dhanaraju, Magharla Dasaratha ^a   Sathyamoorthy, Nandhakumar ^a   Sundar, Vankayalu Devendiran ^a   Suresh, C ^b  

^a GIET School of Pharmacy   (India)

^b VELS INSTITUTE OF SCIENCE   (India)

Author keywords

Biodegradable; In vitro release; Microspheres; Polymeric drug delivery

Indexed keywords

ETOPOSIDE; MICROSPHERE; POLYCAPROLACTONE;

ARTICLE; DRUG FORMULATION; ENCAPSULATION; EVAPORATION; IN VITRO STUDY; PARTICLE SIZE; PHYSICAL CHEMISTRY; SUSTAINED DRUG RELEASE;

EID: 78349257750     PISSN: 18180876     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. M. Kanke, G. H. Simmons, D. L. Weiss, et al. Clearence of 141 Ce-labelled microspheres in specific organs following intravenous and intra arterial administration in Beagle dogs. J. Pharm. Sci., 1980, 69: 755-762.
2. L. Illum, S. S. David. Targeting of colloidal particles to the bone marrow. Life Sci., 1987, 40: 1553-1560.
3. A. Gupte, K. Ciftci. Formulation and characterization of paclitaxel, 5-FU and paclitaxel + 5-FU microspheres. Int. J. Pharm., 2004, 276: 93-106.
4. T. Chandy, G. S. Das, R. F. Wilson, et al. Development of polylactide microspheres for protein encapsulation and delivery. J. Appl. Polym Sci., 2002, 86: 1285-1295.
5. M. Shi, Y. Y. Yang, C. S. Chaw, et al. Double walled POE/PLGA microspheres: encapsulation of water soluble and water insoluble proteins and their release properties. J. Control. Release, 2003, 89: 167-177.
6. X. Fu, Q. Ping, Y. Gao. Effects of formulation factors on encapsulation efficiency and release behavior in vitro of luperzine PLGA microspheres. J. Microenc., 2003, 22: 705-714. (Pubitemid 43158192)
7. Z. Shaoabing, D. Xianmo, Y. Hua. Biodegradable poly (ε-caprolactone) - poly (ethyleneglycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials., 2003, 24: 3563-3570.
8. M. Chasin, R. Langer. Biodegradable polymers as drug delivery systems. New York, NY: Marcel. Dekker, Inc., 1990.
9. V. R. Sinha, K. Bansal, R. Kaushik, et al. Polycaprolactone microspheres and nanospheres: an overview. Int. J. Pharm., 2004, 278: 1-23.
10. K. R. Hande. Etoposide: four decades of development of a topoisomerase II inhibitor. Eur. J. Cancer., 1998, 34: 1514-1521.
11. S. N. Wolf, W. W. Grosh, K. Prater. In vitro pharmacodynamic evaluation of VP-16213 and implications for chemotherapy. Cancer. Chemother. Pharmacol., 1987,19: 246-249.
12. H. Sato, Y. M. Wang, I. Adachi, et al. Pharmacokinetic study of taxol- loaded poly (lactic-co-glycolic acid) microspheres containing isopropyl myristate after targeted delivery to the lung in mice. Biol. Pharm. Bull., 1996, 19: 1596-1601.
13. Y. W. Wang, H. Sato, I. Adachi, et al. Preparation and characterization of poly (lactic-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, taxol. Chem. Pharm. Bull (Tokyo)., 1996, 44: 1935-1940.
14. H. S. Ciftci, A. A. Hincal, T. M. Ercan, et al. In vitro and in vivo evaluation of PLAGA (50/50) microspheres containing 5-Fluorouracil prepared by a solvent evaporation method. Int. J. Pharm., 1996, 13: 73-82.
15. S. C. Martinez, V. R. Herrero, S. Negro. Poly (D, L-lactideco- glycolide) microspheres for long term intravitreal delivery of acyclovir: influence of fatty and non-fatty additives. J. Microenc., 2003, 20: 799-810.
16. M. H. Perez, C. Zinutti, A. Lamprecht, et al. The preparation and evaluation of poly (?-caprolactone) microparticles containing both lipophilic and hydrophilic drug. J. Control. Release, 2000, 65: 429-438.
17. H. Jeffery, S. S. Davis, D. T. Ohagan. The preparation of poly (lactide-co-glycolide) microparticles, oil in water emulsion solvent evaporation. Int. J. Pharm., 1991, 77: 169-175.
18. Y. M. Wang, H. Sato, I. Adachi, et al. Preparation and characterization of poly (lactide-co-glycolic acid) microspheres for targeted delivery of a novel anticancer agent, Taxol. Chem. Pharm. Bull., 1996, 44: 1935-1940.
19. L. Mu, S. S. Feng. Vitamin E TPGS used as emulsifier in the solvent evaporation extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol). J. Control. Release, 2002, 80: 129-144.
20. M. A. Benoit, B. Baras, J. Gillard. Preparation and characterization of protein loaded poly (ε-caprolactone) microparticles for oral vaccine delivery. Int. J. Pharm., 1999, 184: 73-84.
21. A. Lamprecht, N. Ubrich, M. Hombriero Perez, et al. Biodegradable monodispersed nano particles prepared by pressure homogenization emulsification. Int. J. Pharm., 1999, 184, 97-105
22. R. T. Liggins, S. D. Amours, J. S. Dematrick, et al. Paclitaxel loaded poly (L-lactic acid) microspheres for the prevention of intraperitonial carcinomatosis after a surgical repair and tumor cell spill. Biomaterials., 2000, 21: 1959-1969.
23. R. Bodmeier, H. Chem. The preparation and characterization of microspheres containing the antiinflammatory agents indomethacin, ibuprofen and ketoprofen. J. Control. Release., 1989, 10: 167-175.
24. C. Yan, J. H. Resau, J. Hewestan, et al. Characterization and morphological analysis of protein loaded poly (lactideco-glycolide) microparticles prepared by water in-oil-in water emulsion technique. J. control. Release., 1994, 32: 231-241.
25. V. R. Sinha, A. Trehan. Formulation, characterization, and evaluation of Ketorolac tromethamine-loaded biodegradable microspheres. Drug. Delivery., 2005, 12, 133-139.
26. M. D. Dhanaraju, K. Vema, R. Jayakumar, et al. Preparation and characterization of injectable microspheres of contraceptive hormones. Int. J. Pharm., 2003, 268: 23-29.
27. A. B. Dhanikula, R. Panchagnula. Localized paclitaxel delivery. Int. J. Pharm., 1999, 183: 85-100.